Oct 8, 2019 Cellectar Announces Presentation at the Cancer Research UK-AACR Joint Conference on Engineering and Physical Sciences in Oncology Learn More
Sep 30, 2019 Cellectar Presents Data from DLBCL Cohort of its Phase 2 CLOVER-1 Study at the European Society for Medical Oncology (ESMO) Congress Learn More
Sep 24, 2019 Cellectar Receives Orphan Drug Designation from the European Commission for CLR 131 in Multiple Myeloma Learn More
Sep 19, 2019 Cellectar Biosciences to Present at the Ladenburg Thalmann 2019 Healthcare Conference Learn More